{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:51:39Z","timestamp":1769514699320,"version":"3.49.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2825,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2007.08272.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T11:27:37Z","timestamp":1279711657000},"page":"41-46","source":"Crossref","is-referenced-by-count":45,"special_numbering":"supplement s2","title":["Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head"],"prefix":"10.1093","volume":"157","author":[{"given":"E.","family":"Stockfleth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sterry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carey-Yard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis","volume":"141","author":"Korman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00042728-200506000-00008","article-title":"Long term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream","volume":"31","author":"Lee","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled clinical trial with histology","volume":"51","author":"Szeimies","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2002.126257","article-title":"Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: an open label trial","volume":"47","author":"Salasche","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2007.08272.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.sder.2005.06.002","article-title":"The pitfalls of treating all actinic keratoses as squamous cell carcinomas","volume":"24","author":"Wheeland","year":"2005","journal-title":"Semin Cutan Med Surg"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2007.08272.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2007.08272.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:23:13Z","timestamp":1676366593000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/157\/s2\/41\/6640734"}},"subtitle":["Multicentre, open-label study using imiquimod"],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":6,"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08272.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}